scholarly article | Q13442814 |
P356 | DOI | 10.1016/0301-2115(95)02138-W |
P698 | PubMed publication ID | 7556837 |
P2093 | author name string | T Reissmann | |
K Diedrich | |||
W Küpker | |||
C Diedrich | |||
O Bauer | |||
R E Felberbaum | |||
S al Hasani | |||
P433 | issue | 2 | |
P304 | page(s) | 151-155 | |
P577 | publication date | 1995-08-01 | |
P1433 | published in | European Journal of Obstetrics Gynecology and Reproductive Biology | Q15755730 |
P1476 | title | Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility | |
P478 | volume | 61 |
Q92308887 | Administration effects of single-dose GnRH agonist for luteal support in females undertaking IVF/ICSI cycles: A meta-analysis of randomized controlled trials |
Q35165328 | An overview of GnRH antagonists in infertility treatments. Introduction |
Q34034016 | Clinical application of GnRH-antagonists |
Q43957485 | Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study |
Q50723279 | Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, cetrorelix, and GnRH agonists. |
Q36271008 | Effect of in vivo GnRH agonist and GnRH antagonist on hCG and insulin-stimulated progesterone production by human granulosa-lutein cells in vitro |
Q44131161 | Effectiveness of an antagonist to gonadotrophin releasing hormone on the FSH and LH response to GnRH in perifused equine pituitary cells, and in seasonally acyclic mares |
Q36094997 | Extrapituitary effects of GnRH antagonists in assisted reproduction: a review |
Q34573314 | GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis |
Q35049420 | Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action. |
Q24245006 | Gonadotrophin-releasing hormone antagonists for assisted conception |
Q33284961 | Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review |
Q24185849 | Gonadotrophin-releasing hormone antagonists for assisted reproductive technology |
Q24234608 | Gonadotrophin-releasing hormone antagonists for assisted reproductive technology |
Q40601455 | Gonadotrophin-releasing hormone antagonists: will they replace the agonists? |
Q24234765 | Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles |
Q24236630 | Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles |
Q24241061 | Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles |
Q24193015 | Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology |
Q43672714 | Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders |
Q34457474 | Gonadotropin-releasing-hormone-receptor antagonists |
Q49017837 | Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages |
Q34683548 | Impact of ovarian stimulation on corpus luteum function and embryonic implantation |
Q35690393 | Impact of whole systems traditional Chinese medicine on in-vitro fertilization outcomes |
Q36984419 | Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol |
Q33944146 | Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization |
Q50644764 | Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. |
Q37022412 | The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles |
Q35049436 | The luteal phase after ovarian stimulation. |
Q35049429 | The role of GnRH antagonists in assisted reproduction. |
Q54622516 | The role of LHRH agonists and antagonists. |
Q24816913 | The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment |
Q36093450 | Use of antagonists in ovarian stimulation protocols |
Q88990640 | What should be the protocol selection after failure of in-vitro fertilization at normoresponder patients: Agonist or antagonist? |
Search more.